{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:07:38Z","timestamp":1781651258215,"version":"3.54.5"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,9,22]],"date-time":"2012-09-22T00:00:00Z","timestamp":1348272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00223-012-9651-0","type":"journal-article","created":{"date-parts":[[2012,9,21]],"date-time":"2012-09-21T05:53:32Z","timestamp":1348206812000},"page":"297-306","source":"Crossref","is-referenced-by-count":16,"title":["Hypophosphatemic Rickets: Unraveling the Role of FGF23"],"prefix":"10.1007","volume":"91","author":[{"given":"John M.","family":"Pettifor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebashni","family":"Thandrayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,22]]},"reference":[{"key":"9651_CR1","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJM199406093302310","volume":"330","author":"MJ Econs","year":"1994","unstructured":"Econs MJ, Drezner MK (1994) Tumor-induced osteomalacia\u2014unveiling a new hormone. N Engl J Med 330:1679\u20131681","journal-title":"N Engl J Med"},{"key":"9651_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ndt\/12.1.11","volume":"12","author":"R Kumar","year":"1997","unstructured":"Kumar R (1997) Phosphatonin\u2014a new phosphaturetic hormone? (lessons from tumour-induced osteomalacia and X-linked hypophosphataemia). Nephrol Dial Transplant 12:11\u201313","journal-title":"Nephrol Dial Transplant"},{"key":"9651_CR3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"KE White","year":"2000","unstructured":"White KE, Evans WE, O\u2019Riordan JL, Speer MC, Econs MJ, Lorenz-Depiereux B, Grabowski M, Meitinger T, Strom TM (2000) Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26:345\u2013348","journal-title":"Nat Genet"},{"key":"9651_CR4","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18:R53\u2013R77","journal-title":"Endocr Relat Cancer"},{"key":"9651_CR5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","volume":"112","author":"M Riminucci","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron RP (2003) FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 112:683\u2013692","journal-title":"J Clin Invest"},{"key":"9651_CR6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1138\/20110516","volume":"8","author":"R Sapir-Koren","year":"2011","unstructured":"Sapir-Koren R, Livshits G (2011) Bone mineralization and regulation of phosphate homeostasis. IBMS BoneKEy 8:286\u2013300","journal-title":"IBMS BoneKEy"},{"key":"9651_CR7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/jbmr.294","volume":"26","author":"R Zhang","year":"2011","unstructured":"Zhang R, Lu Y, Ye L, Yuan B, Yu S, Qin C, Xie Y, Gao T, Drezner MK, Bonewald LF, Feng JQ (2011) Unique roles of phosphorus in endochondral bone formation and osteocyte maturation. J Bone Miner Res 26:1047\u20131056","journal-title":"J Bone Miner Res"},{"key":"9651_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2011.08.030","volume":"347","author":"F Perwad","year":"2011","unstructured":"Perwad F, Portale AA (2011) Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23. Mol Cell Endocrinol 347:17\u201324","journal-title":"Mol Cell Endocrinol"},{"key":"9651_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00002.2011","volume":"92","author":"A Martin","year":"2012","unstructured":"Martin A, David V, Quarles LD (2012) Regulation and function of the FGF23\/Klotho endocrine pathways. Physiol Rev 92:131\u2013155","journal-title":"Physiol Rev"},{"key":"9651_CR10","doi-asserted-by":"crossref","first-page":"F371","DOI":"10.1152\/ajprenal.00740.2010","volume":"301","author":"J Gattineni","year":"2011","unstructured":"Gattineni J, Twombley K, Goetz R, Mohammadi M, Baum M (2011) Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4. Am J Physiol Renal Physiol 301:F371\u2013F377","journal-title":"Am J Physiol Renal Physiol"},{"key":"9651_CR11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrendo.2011.218","volume":"8","author":"LD Quarles","year":"2012","unstructured":"Quarles LD (2012) Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol 8:276\u2013286","journal-title":"Nat Rev Endocrinol"},{"key":"9651_CR12","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","volume":"60","author":"KE White","year":"2001","unstructured":"White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079\u20132086","journal-title":"Kidney Int"},{"key":"9651_CR13","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/en.143.8.3179","volume":"143","author":"T Shimada","year":"2002","unstructured":"Shimada T, Muto T, Urakawa I, Yoneya T, Yamazaki Y, Okawa K, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2002) Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143:3179\u20133182","journal-title":"Endocrinology"},{"key":"9651_CR14","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/MCB.02249-06","volume":"27","author":"R Goetz","year":"2007","unstructured":"Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, Xu C, Neubert TA, Zhang F, Linhardt RJ, Yu X, White KE, Inagaki T, Kliewer SA, Yamamoto M, Kurosu H, Ogawa Y, Kuro-o M, Lanske B, Razzaque MS, Mohammadi M (2007) Molecular insights into the Klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol 27:3417\u20133428","journal-title":"Mol Cell Biol"},{"key":"9651_CR15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","volume":"107","author":"R Goetz","year":"2010","unstructured":"Goetz R, Nakada Y, Hu MC, Kurosu H, Wang L, Nakatani T, Shi M, Eliseenkova AV, Razzaque MS, Moe OW, Kuro-o M, Mohammadi M (2010) Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation. Proc Natl Acad Sci USA 107:407\u2013412","journal-title":"Proc Natl Acad Sci USA"},{"key":"9651_CR16","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","volume":"280","author":"H Saito","year":"2005","unstructured":"Saito H, Maeda A, Ohtomo Si, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto Ki, Fukushima N (2005) Circulating FGF-23 is regulated by 1\u03b1,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280:2543\u20132549","journal-title":"J Biol Chem"},{"key":"9651_CR17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","volume":"90","author":"SL Ferrari","year":"2005","unstructured":"Ferrari SL, Bonjour JP, Rizzoli R (2005) Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. J Clin Endocrinol Metab 90:1519\u20131524","journal-title":"J Clin Endocrinol Metab"},{"key":"9651_CR18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00774-007-0779-3","volume":"25","author":"N Ito","year":"2007","unstructured":"Ito N, Fukumoto S, Takeuchi Y, Takeda S, Suzuki H, Yamashita T, Fujita T (2007) Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab 25:419\u2013422","journal-title":"J Bone Miner Metab"},{"key":"9651_CR19","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MNH.0b013e328351a391","volume":"21","author":"T Isakova","year":"2012","unstructured":"Isakova T (2012) Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens 21:334\u2013340","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"9651_CR20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4614-0887-1_8","volume":"728","author":"P Wahl","year":"2012","unstructured":"Wahl P, Wolf M (2012) FGF23 in chronic kidney disease. Adv Exp Med Biol 728:107\u2013125","journal-title":"Adv Exp Med Biol"},{"key":"9651_CR21","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2011101006","volume":"23","author":"ME Rodriguez-Ortiz","year":"2012","unstructured":"Rodriguez-Ortiz ME, Lopez I, Munoz-Castaneda JR, Martinez-Moreno JM, Ramirez AP, Pineda C, Canalejo A, Jaeger P, Aguilera-Tejero E, Rodriguez M, Felsenfeld A, Almaden Y (2012) Calcium deficiency reduces circulating levels of FGF23. J Am Soc Nephrol 23:1190\u20131197","journal-title":"J Am Soc Nephrol"},{"key":"9651_CR22","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jbmr.69","volume":"25","author":"V David","year":"2010","unstructured":"David V, Quarles LD (2010) ASARM mineralization hypothesis: a bridge too far? J Bone Miner Res 25:692\u2013694","journal-title":"J Bone Miner Res"},{"key":"9651_CR23","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","volume":"38","author":"JQ Feng","year":"2006","unstructured":"Feng JQ, Ward LM, Liu S, Lu Y, Xie Y, Yuan B, Yu X, Rauch F, Davis SI, Zhang S, Rios H, Drezner MK, Quarles LD, Bonewald LF, White KE (2006) Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 38:1310\u20131315","journal-title":"Nat Genet"},{"key":"9651_CR24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jbmr.226","volume":"26","author":"Y Lu","year":"2011","unstructured":"Lu Y, Yuan B, Qin C, Cao Z, Xie Y, Dallas SL, McKee MD, Drezner MK, Bonewald LF, Feng JQ (2011) The biological function of DMP-1 in osteocyte maturation is mediated by its 57-kDa C-terminal fragment. J Bone Miner Res 26:331\u2013340","journal-title":"J Bone Miner Res"},{"key":"9651_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","volume":"86","author":"V Levy-Litan","year":"2010","unstructured":"Levy-Litan V, Hershkovitz E, Avizov L, Leventhal N, Bercovich D, Chalifa-Caspi V, Manor E, Buriakovsky S, Hadad Y, Goding J, Parvari R (2010) Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet 86:273\u2013278","journal-title":"Am J Hum Genet"},{"key":"9651_CR26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","author":"HYP Consortium","year":"1995","unstructured":"HYP Consortium (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130\u2013136","journal-title":"Nat Genet"},{"key":"9651_CR27","doi-asserted-by":"crossref","first-page":"F783","DOI":"10.1152\/ajprenal.00304.2010","volume":"300","author":"V David","year":"2011","unstructured":"David V, Martin A, Hedge AM, Drezner MK, Rowe PSN (2011) ASARM peptides: PHEX-dependent and -independent regulation of serum phosphate. Am J Physiol Renal Physiol 300:F783\u2013F791","journal-title":"Am J Physiol Renal Physiol"},{"key":"9651_CR28","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2009-0472","volume":"150","author":"R Samadfam","year":"2009","unstructured":"Samadfam R, Richard C, Nguyen-Yamamoto L, Bolivar I, Goltzman D (2009) Bone formation regulates circulating concentrations of fibroblast growth factor 23. Endocrinology 150:4835\u20134845","journal-title":"Endocrinology"},{"key":"9651_CR29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1258\/000456307781646102","volume":"44","author":"BH Durham","year":"2007","unstructured":"Durham BH, Joseph F, Bailey LM, Fraser WD (2007) The association of circulating ferritin with serum concentrations of fibroblast growth factor-23 measured by three commercial assays. Ann Clin Biochem 44:463\u2013466","journal-title":"Ann Clin Biochem"},{"key":"9651_CR30","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1210\/jc.2011-1239","volume":"96","author":"EA Imel","year":"2011","unstructured":"Imel EA, Peacock M, Gray AK, Padgett LR, Hui SL, Econs MJ (2011) Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. J Clin Endocrinol Metab 96:3541\u20133549","journal-title":"J Clin Endocrinol Metab"},{"key":"9651_CR31","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bone.2007.11.014","volume":"42","author":"A Prentice","year":"2008","unstructured":"Prentice A, Ceesay M, Nigdikar S, Allen SJ, Pettifor JM (2008) FGF23 is elevated in Gambian children with rickets. Bone 42:788\u2013797","journal-title":"Bone"},{"key":"9651_CR32","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bone.2012.03.010","volume":"50","author":"V Braithwaite","year":"2012","unstructured":"Braithwaite V, Jarjou LMA, Goldberg GR, Prentice A (2012) Iron status and fibroblast growth factor-23 in Gambian children. Bone 50:1351\u20131356","journal-title":"Bone"},{"key":"9651_CR33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00774-009-0079-1","volume":"27","author":"D Tiosano","year":"2009","unstructured":"Tiosano D, Hochberg Z (2009) Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab 27:392\u2013401","journal-title":"J Bone Miner Metab"},{"key":"9651_CR34","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1073\/pnas.0502249102","volume":"102","author":"Y Sabbagh","year":"2005","unstructured":"Sabbagh Y, Carpenter TO, Demay MB (2005) Hypophosphatemia leads to rickets by impairing caspase-mediated apoptosis of hypertrophic chondrocytes. Proc Natl Acad Sci USA 102:9637\u20139642","journal-title":"Proc Natl Acad Sci USA"},{"key":"9651_CR35","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","volume":"24","author":"Y Aono","year":"2009","unstructured":"Aono Y, Yamazaki Y, Yasutake J, Kawata T, Hasegawa H, Urakawa I, Fujita T, Wada M, Yamashita T, Fukumoto S, Shimada T (2009) Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia. J Bone Miner Res 24:1879\u20131888","journal-title":"J Bone Miner Res"},{"key":"9651_CR36","doi-asserted-by":"crossref","first-page":"E1636","DOI":"10.1152\/ajpendo.00396.2007","volume":"293","author":"S Liu","year":"2007","unstructured":"Liu S, Tang W, Zhou J, Vierthaler L, Quarles LD (2007) Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice. Am J Physiol Endocrinol Metab 293:E1636\u2013E1644","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9651_CR37","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM198010303031802","volume":"303","author":"FH Glorieux","year":"1980","unstructured":"Glorieux FH, Marie PJ, Pettifor JM, Delvin EE (1980) Bone response to phosphate salts, ergocalciferol and calcitriol in hypophosphatemic vitamin-D resistant rickets. N Engl J Med 303:1023\u20131031","journal-title":"N Engl J Med"},{"key":"9651_CR38","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1172\/JCI110110","volume":"67","author":"PJ Marie","year":"1981","unstructured":"Marie PJ, Travers R, Glorieux FH (1981) Healing of rickets with phosphate supplementation in the hypophosphatemic male mouse. J Clin Invest 67:911\u2013914","journal-title":"J Clin Invest"},{"key":"9651_CR39","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","volume":"42","author":"I Endo","year":"2008","unstructured":"Endo I, Fukumoto S, Ozono K, Namba N, Tanaka H, Inoue D, Minagawa M, Sugimoto T, Yamauchi M, Michigami T, Matsumoto T (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone 42:1235\u20131239","journal-title":"Bone"},{"key":"9651_CR40","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1507\/endocrj.K10E-257","volume":"58","author":"JM Igaki","year":"2011","unstructured":"Igaki JM, Yamada M, Yamazaki Y, Koto S, Izawa M, Ariyasu D, Suzuki E, Hasegawa H, Hasegawa Y (2011) High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH. Endocr J 58:647\u2013655","journal-title":"Endocr J"},{"key":"9651_CR41","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656\u20131663","journal-title":"N Engl J Med"},{"key":"9651_CR42","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","volume":"91","author":"EA Imel","year":"2006","unstructured":"Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91:2055\u20132061","journal-title":"J Clin Endocrinol Metab"},{"key":"9651_CR43","doi-asserted-by":"crossref","first-page":"E352","DOI":"10.1210\/jc.2010-0589","volume":"95","author":"TO Carpenter","year":"2010","unstructured":"Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, Olear E, Gundberg CM (2010) Circulating levels of soluble Klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J Clin Endocrinol Metab 95:E352\u2013E357","journal-title":"J Clin Endocrinol Metab"},{"key":"9651_CR44","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.2009-1671","volume":"95","author":"EA Imel","year":"2010","unstructured":"Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ (2010) Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 95:1846\u20131850","journal-title":"J Clin Endocrinol Metab"},{"key":"9651_CR45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00774-011-0298-0","volume":"29","author":"S Fukumoto","year":"2011","unstructured":"Fukumoto S, Shimizu Y (2011) Fibroblast growth factor 23 as a phosphotropic hormone and beyond. J Bone Miner Metab 29:507\u2013514","journal-title":"J Bone Miner Metab"},{"key":"9651_CR46","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1210\/jc.2012-1811","volume":"97","author":"ER Smith","year":"2012","unstructured":"Smith ER, Cai MM, McMahon LP, Holt SG (2012) Biological variability of plasma intact and C-terminal FGF23 measurements. J Clin Endocrinol Metab 97:3357\u20133365","journal-title":"J Clin Endocrinol Metab"},{"key":"9651_CR47","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","volume":"108","author":"EG Farrow","year":"2011","unstructured":"Farrow EG, Yu X, Summers LJ, Davis SI, Fleet JC, Allen MR, Robling AG, Stayrook KR, Jideonwo V, Magers MJ, Garringer HJ, Vidal R, Chan RJ, Goodwin CB, Hui SL, Peacock M, White KE (2011) Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci USA 108:E1146\u2013E1155","journal-title":"Proc Natl Acad Sci USA"},{"key":"9651_CR48","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jbmr.316","volume":"26","author":"P Andreopoulou","year":"2011","unstructured":"Andreopoulou P, Dumitrescu CE, Kelly MH, Brillante BA, Cutler Peck CM, Wodajo FM, Chang R, Collins MT (2011) Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res 26:1295\u20131302","journal-title":"J Bone Miner Res"},{"key":"9651_CR49","doi-asserted-by":"crossref","first-page":"794","DOI":"10.5732\/cjc.011.10013","volume":"30","author":"FK Hu","year":"2011","unstructured":"Hu FK, Yuan F, Jiang CY, Lv DW, Mao BB, Zhang Q, Yuan ZQ, Wang Y (2011) Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature. Chin J Cancer 30:794\u2013804","journal-title":"Chin J Cancer"},{"key":"9651_CR50","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"TO Carpenter","year":"2011","unstructured":"Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res 26:1381\u20131388","journal-title":"J Bone Miner Res"},{"key":"9651_CR51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-263X.1998.00059.x","volume":"8","author":"JR Goodman","year":"1998","unstructured":"Goodman JR, Gelbier MJ, Bennett JH, Winter GB (1998) Dental problems associated with hypophosphatemic vitamin D resistant rickets. Int J Paediatr Dent 8:19\u201328","journal-title":"Int J Paediatr Dent"},{"key":"9651_CR52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00223-009-9270-6","volume":"85","author":"G Liang","year":"2009","unstructured":"Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM (2009) Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice. Calcif Tissue Int 85:235\u2013246","journal-title":"Calcif Tissue Int"},{"key":"9651_CR53","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1601-0825.2006.01326.x","volume":"13","author":"C Chaussain-Miller","year":"2007","unstructured":"Chaussain-Miller C, Sinding C, Septier D, Wolikow M, Goldberg M, Garabedian M (2007) Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment. Oral Dis 13:482\u2013489","journal-title":"Oral Dis"},{"key":"9651_CR54","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJM199112263252604","volume":"325","author":"CF Verge","year":"1991","unstructured":"Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ, Silink M (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843\u20131848","journal-title":"N Engl J Med"},{"key":"9651_CR55","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archsurg.139.2.218","volume":"139","author":"RM Savio","year":"2004","unstructured":"Savio RM, Gosnell JE, Posen S, Reeve TS, Delbridge LW (2004) Parathyroidectomy for tertiary hyperparathyroidism associated with X-linked dominant hypophosphatemic rickets. Arch Surg 139:218\u2013222","journal-title":"Arch Surg"},{"key":"9651_CR56","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","volume":"87","author":"SS Beck-Nielsen","year":"2010","unstructured":"Beck-Nielsen SS, Brusgaard K, Rasmussen LM, Brixen K, Brock-Jacobsen B, Poulsen MR, Vestergaard P, Ralston SH, Albagha OM, Poulsen S, Haubek D, Gjorup H, Hintze H, Andersen MG, Heickendorff L, Hjelmborg J, Gram J (2010) Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int 87:108\u2013119","journal-title":"Calcif Tissue Int"},{"key":"9651_CR57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0169-6009(91)90038-2","volume":"12","author":"MB Oliveri","year":"1991","unstructured":"Oliveri MB, Cassinelli H, Bergada C, Mautalen CA (1991) Bone mineral density of the spine and radius shaft in children with X-linked hypophosphatemic rickets (XLH). Bone Miner 12:91\u2013100","journal-title":"Bone Miner"},{"key":"9651_CR58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9343(91)90507-T","volume":"90","author":"IR Reid","year":"1991","unstructured":"Reid IR, Murphy WA, Hardy DC, Teitelbaum SL, Bergfeld MA, Whyte MP (1991) X-linked hypophosphatemia: skeletal mass in adults assessed by histomorphometry, computed tomography, and absorptiometry. Am J Med 90:63\u201369","journal-title":"Am J Med"},{"key":"9651_CR59","doi-asserted-by":"crossref","unstructured":"Fukumoto S (2012) What\u2019s new in FGF23 research? BoneKEy Rep. doi: 10.1038\/bonekey.2012.111","DOI":"10.1038\/bonekey.2012.111"},{"key":"9651_CR60","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1359\/jbmr.080417","volume":"23","author":"Y Yamazaki","year":"2008","unstructured":"Yamazaki Y, Tamada T, Kasai N, Urakawa I, Aono Y, Hasegawa H, Fujita T, Kuroki R, Yamashita T, Fukumoto S, Shimada T (2008) Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J Bone Miner Res 23:1509\u20131518","journal-title":"J Bone Miner Res"},{"key":"9651_CR61","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1056\/NEJMc1010928","volume":"364","author":"ES Liu","year":"2011","unstructured":"Liu ES, Carpenter TO, Gundberg CM, Simpson CA, Insogna KL (2011) Calcitonin administration in X-linked hypophosphatemia. N Engl J Med 364:1678\u20131680","journal-title":"N Engl J Med"},{"key":"9651_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00774-011-0340-2","volume":"30","author":"T Carpenter","year":"2012","unstructured":"Carpenter T (2012) The expanding family of hypophosphatemic syndromes. J Bone Miner Metab 30:1\u20139","journal-title":"J Bone Miner Metab"},{"key":"9651_CR63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2010.01.006","volume":"86","author":"B Lorenz-Depiereux","year":"2010","unstructured":"Lorenz-Depiereux B, Schnabel D, Tiosano D, Hausler G, Strom TM (2010) Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets. Am J Hum Genet 86:267\u2013272","journal-title":"Am J Hum Genet"},{"key":"9651_CR64","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1359\/jbmr.2000.15.1.120","volume":"15","author":"P Bianco","year":"2000","unstructured":"Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins MT, Mankani MH, Corsi A, Bone HG, Wientroub S, Spiegel AM, Fisher LW, Robey JG (2000) Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 15:120\u2013128","journal-title":"J Bone Miner Res"},{"key":"9651_CR65","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.0712361105","volume":"105","author":"CA Brownstein","year":"2008","unstructured":"Brownstein CA, Adler F, Nelson-Williams C, Iijima J, Li P, Imura A, Nabeshima Yi, Reyes-Mugica M, Carpenter TO, Lifton RP (2008) A translocation causing increased \u03b1-Klotho level results in hypophosphatemic rickets and hyperparathyroidism. Proc Natl Acad Sci USA 105:3455\u20133460","journal-title":"Proc Natl Acad Sci USA"},{"key":"9651_CR66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/499410","volume":"78","author":"B Lorenz-Depiereux","year":"2006","unstructured":"Lorenz-Depiereux B, et-Pages A, Eckstein G, Tenenbaum-Rakover Y, Wagenstaller J, Tiosano D, Gershoni-Baruch R, Albers N, Lichtner P, Schnabel D, Hochberg Z, Strom TM (2006) Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet 78:193\u2013201","journal-title":"Am J Hum Genet"},{"key":"9651_CR67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11154-008-9075-3","volume":"9","author":"M Bastepe","year":"2008","unstructured":"Bastepe M, Juppner H (2008) Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev Endocr Metab Disord 9:171\u2013180","journal-title":"Rev Endocr Metab Disord"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-012-9651-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-012-9651-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-012-9651-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:41:04Z","timestamp":1558698064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-012-9651-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,22]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["9651"],"URL":"https:\/\/doi.org\/10.1007\/s00223-012-9651-0","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,22]]}}}